definiens: means, collectively, any and all pharmaceutical p roducts of Sellers or any of their respective Controlled Affiliates that as o f the date hereof and at Closing are sold or intend ed to be sold in the United States as Generic Drugs ( including brand ed generic pharmaceutical products and generic over the counter products, but excluding biologics or other biosimilar product ), including authorized generic pharmaceutical products that have been launched or available for launch on or prior to Closing and all such products or other assets that ( i ) are being or have been researched, tested, developed, commercialized, manufactured, sold, promoted or distributed by Sell ers or any of their respective Affiliates in the Un ited States as of the date hereof and at Closing, including those listed on Schedule 1.1(g ), or ( ii ) are owned by, li censed to or otherwise used pursuant to a Contract by the Seller s or any of their Affiliates or introduced into com merce by any of the Sellers or their respective Affiliates as of the date hereof and at Closing